GlassScriptPhysician profile
Amber Riecken
NPI 1508449893
$6,214.01
in general payments reported to CMS, 2019-2025
37 companies · $765 in 2025
The $765 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $373 · 2022: $1,065 · 2023: $1,513 · 2024: $2,498 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,444 · Travel and Lodging: $1,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,443.72 |
| Travel and Lodging | $1,332.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,817.60 | 2023-2024 | Axonics |
| Abbvie INC. | $523.87 | 2021-2025 | |
| 180 Medical, INC. | $451.22 | 2021-2025 | Gentlecath, Cure Ultra Catheter, Cure Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $292.26 | 2022-2024 | |
| Accord Healthcare, INC. | $264.25 | 2022-2025 | |
| Janssen Biotech, INC. | $264.23 | 2022-2025 | Erleada, Akeega |
| Teleflex LLC | $228.60 | 2022-2025 | Urolift |
| Merck Sharp & Dohme LLC | $210.43 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astellas Pharma US INC | $179.61 | 2022-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $173.49 | 2021-2023 | Provenge |
| Sumitomo Pharma America, INC. | $161.71 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar, INC. | $154.76 | 2023-2025 | Jatenzo, Eligard |
| Ferring Pharmaceuticals INC. | $153.82 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $147.18 | 2024-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Lithovue |
| Janssen Scientific Affairs, LLC | $117.78 | 2023 | Balversa, Erleada, Pipeline |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $115.66 | 2021-2022 | |
| Urogen Pharma, INC. | $115.38 | 2023-2025 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $96.16 | 2021-2022 | |
| Urovant Sciences INC | $89.29 | 2021-2022 | |
| Pfizer INC. | $79.00 | 2022-2025 | |
| Procept Biorobotics Corporation | $73.50 | 2022-2024 | Aquabeam System |
| C. R. Bard, INC. & Subsidiaries | $63.66 | 2023-2025 | Bard Urinary Drainage Bag, Purewick Female External Catheter |
| Progenics Pharmaceuticals, INC. | $58.67 | 2023-2025 | Pylarify |
| Travere Therapeutics, INC. | $51.52 | 2021-2022 | |
| Blue Earth Diagnostics | $47.75 | 2021-2022 | |
| Palette Life Sciences, INC. | $46.28 | 2022-2023 | |
| Becton, Dickinson and Company | $44.64 | 2023-2024 | Bard Urinary Drainage Bag |
| Smith+Nephew, INC. | $26.16 | 2023 | Stravix |
| Agiliti Surgical, INC. | $26.12 | 2022 | |
| Antares Pharma, INC. | $21.07 | 2024 | Xyosted |
| Immunitybio, INC. | $20.58 | 2024 | |
| Verity Pharmaceuticals INC. | $18.30 | 2024 | Trelstar |
| Rochester Medical Corporation | $18.28 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.67 | 2024 | |
| Coloplast Corp | $15.98 | 2023 | Speedicath |
| Photocure INC | $15.90 | 2023 | Cysview |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Riecken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.